DOJ Chases Positive Overdose Numbers With More Funding

Attorney General Jeff Sessions announces new strategic actions to combat the opioid crisis at the Department of Justice's National Opioid Summit in Washington, D.C. on Thursday.

Attorney General Jeff Sessions announces new strategic actions to combat the opioid crisis at the Department of Justice's National Opioid Summit in Washington, D.C. on Thursday. Alex Brandon / AP Photo

 

Connecting state and local government leaders

Attorney General Jeff Sessions announced a new “strike force” to investigate and prosecute prescription opioid abuse in Appalachia.

WASHINGTON — The Department of Justice is doling out $69.7 million to help states and localities with opioid enforcement and treatment, after preliminary data from the Centers for Disease Control and Prevention showed a modest downturn in drug overdose deaths.

Attorney General Jeff Sessions announced Thursday that the funding is for criminal investigations in states hardest hit by the crisis, as well as counseling, foster care, legal services, and law enforcement and school personnel training to help people addicted to drugs.

About 72,000 Americans died from drug overdoses in 2017, which was a record number. But between September 2017 and March 2018 there was a small drop in deaths, according to CDC’s National Center for Health Statistics.

“The opioid epidemic across America is one that has had tremendous impact on our cities, and collectively we are grateful for the additional funding announced today. As with many addiction problems in our society, we know we cannot arrest our way out of this problem,” Rick Myers, executive director of the Major Cities Chiefs Association, told Route Fifty.

Instead, Myers said that it makes sense to put money into treatment programs that keeps addicts out of jail.

Of the new opioid money, $27.9 million will go to 17 state law enforcement task forces through the Community Oriented Policing Services, or COPS, Office’s Anti-Heroin Task Force Program. That’s two years of funding for agencies’ heroin and opioid investigations in states with high per-capita levels of primary treatment admissions for overdoses.

The Mississippi Bureau of Narcotics will receive the largest award of $2.98 million, followed by the Massachusetts Department of the Attorney General at $2.95 million, and the New Jersey Department of Law and Public Safety at $2.87 million.

Another $7.2 million will go to nine state agencies—ones that regularly seize precursor chemicals, finished methamphetamine, laboratories and dumps—through the COPS Anti-Methamphetamine Program. The Kentucky State Police, South Dakota Attorney General, and Wisconsin Department of Justice will all receive the largest award of $1.03 million.

A final $34.6 million will go toward treatment and assistance through the Office of Victims of Crime. Of that, $29.8 million will be awarded to 41 sites and a technical service provider helping young people.

The maximum site grant of $750,000 is going to 12 sites including the Cook Inlet Tribal Council, Inc. in Alaska, Family Service of Rhode Island, San Antonio Council on Alcohol and Drug Abuse in Texas, and Child Protect of Mercer County, Inc. in West Virginia. Technical service provider JBS International, Inc. will receive $2.5 million.

DOJ will transfer $4.8 million to the Bureau of Justice Assistance to support partnerships between victim service providers and first responders who encounter overdoses where children are present.

“While the total funds announced will have limited impact when spread across the country, it demonstrates that DOJ understands the severity of the problem and is committed to assisting local policing in this effort,” Myers said.

On Wednesday, President Trump signed a package of bills aimed at making opioid addiction treatment more accessible, including through the Medicaid and Medicare programs. The legislation also aims to help crack down on the trafficking of fentanyl and carfentanil into the U.S., and increases research into opioid alternatives. Critics argued that while the package created small grant programs, not enough funding was included for expanding opioid treatment—funding that will come through the appropriations process.

Sessions also announced the creation of the Appalachian Regional Prescription Opioid, or ARPO, Strike Force, made up of  12 opioid fraud prosecutors—each with a team of federal agents. Appalachia has seen “tragically high rates of addiction and overdose,” he said.

ARPO will be based primarily out of Cincinnati and Nashville, Tennessee, and use FBI resources while working with the U.S. Postal Inspection Service, IRS Criminal Investigation and State Medicaid Fraud Control Units.

“They will help us find the doctors, pharmacists, and other medical professionals who are flooding our streets with drugs—and put them behind bars,” Sessions said. “We will be relentless, we will continue to get smarter and better at our work.”

Much of the crisis has been fueled by the medical community overprescribing addictive opioids to mitigate pain, so a strike force addressing the beginning of the cycle is promising, Myers said.

The Trump administration aims to reduce opioid prescriptions by one-third in three years, and they’ve decreased 12 percent in the first eight months of 2018, according to the Drug Enforcement Administration’s national audit.

“The strike force model is a proven mechanism to target illicit conduct and hold accountable criminals involved in illegal opioid prescription and distribution schemes,” said Gary Cantrell, deputy inspector general for investigations in Health and Human Services Office of Inspector General, in a statement.

Dave Nyczepir is a News Editor at Government Executive’s Route Fifty and is based in Washington, D.C.

NEXT STORY: If Parents Get Deported, Who Gets Their Children?

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.